{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:32:23Z","timestamp":1787905943739,"version":"build-2784847793"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.biologicals.2022.01.004","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T12:10:50Z","timestamp":1643026250000},"page":"31-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Evolution of FMT \u2013 From early clinical to standardized treatments"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4924-4511","authenticated-orcid":false,"given":"Stephanie L.","family":"Servetas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3390-751X","authenticated-orcid":false,"given":"Phillip J.","family":"Daschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Guyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4034-9525","authenticated-orcid":false,"given":"Vincent","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herve","family":"Affagard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0477-8680","authenticated-orcid":false,"given":"Chrysi","family":"Sergaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Sokol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Wargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary D.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Sabot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2022.01.004_bib1","doi-asserted-by":"crossref","first-page":"625913","DOI":"10.3389\/fcimb.2021.625913","article-title":"Role and mechanism of gut microbiota in human disease","volume":"11","author":"Chen","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.biologicals.2022.01.004_bib2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40168-017-0296-0","article-title":"(Dis)Trust your gut: the gut microbiome in age-related inflammation, health, and disease","volume":"5","author":"Buford","year":"2017","journal-title":"Microbiome"},{"key":"10.1016\/j.biologicals.2022.01.004_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1158\/1055-9965.EPI-15-0951","article-title":"Collecting fecal samples for microbiome analyses in epidemiology studies","volume":"25","author":"Sinha","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.biologicals.2022.01.004_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/aje\/kww177","article-title":"Comparison of collection methods for fecal samples in microbiome studies","volume":"185","author":"Vogtmann","year":"2017","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.biologicals.2022.01.004_bib5","doi-asserted-by":"crossref","first-page":"10590","DOI":"10.1038\/s41598-021-89881-2","article-title":"An inter-laboratory study to investigate the impact of the bioinformatics component on microbiome analysis using mock communities","volume":"11","author":"O'Sullivan","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.biologicals.2022.01.004_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7100393","article-title":"The impact of bioinformatics pipelines on microbiota studies: does the analytical \u201cmicroscope\u201d affect the biological interpretation?","volume":"7","author":"Siegwald","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.biologicals.2022.01.004_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s40168-020-00856-3","article-title":"Developing standards for the microbiome field","volume":"8","author":"Amos","year":"2020","journal-title":"Microbiome"},{"key":"10.1016\/j.biologicals.2022.01.004_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00525-18","article-title":"Identifying and overcoming threats to reproducibility, replicability, robustness, and generalizability in microbiome research","volume":"9","author":"Schloss","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.biologicals.2022.01.004_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"van Nood","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biologicals.2022.01.004_bib10","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.3748\/wjg.v21.i17.5359","article-title":"Fecal microbiota transplantation as novel therapy in gastroenterology: a systematic review","volume":"21","author":"Rossen","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.biologicals.2022.01.004_bib11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biologicals.2022.01.004_bib12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.20046","article-title":"Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial","volume":"321","author":"Costello","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.biologicals.2022.01.004_bib13","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","article-title":"Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial","volume":"389","author":"Paramsothy","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2022.01.004_bib14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3389\/fnins.2019.00449","article-title":"Co-treatment with BGP-15 exacerbates 5-fluorouracil-induced gastrointestinal dysfunction","volume":"13","author":"McQuade","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.biologicals.2022.01.004_bib15","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.biologicals.2022.01.004_bib16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.biologicals.2022.01.004_bib17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature24460","article-title":"Quantitative microbiome profiling links gut community variation to microbial load","volume":"551","author":"Vandeputte","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biologicals.2022.01.004_bib18","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3389\/fmicb.2020.01469","article-title":"Assessment of Gram- and viability-staining methods for quantifying bacterial community dynamics using flow cytometry","volume":"11","author":"Duquenoy","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.biologicals.2022.01.004_bib19","unstructured":"ClinicalTrials.gov."},{"key":"10.1016\/j.biologicals.2022.01.004_bib20","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/d41573-020-00163-4","article-title":"First microbiome-based drug clears phase III, in clinical trial turnaround","volume":"19","author":"Garber","year":"2020","journal-title":"Nat Rev Drug Discov"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105622000045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105622000045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:15:05Z","timestamp":1760922905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105622000045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":20,"alternative-id":["S1045105622000045"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2022.01.004","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution of FMT \u2013 From early clinical to standardized treatments","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2022.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization.","name":"copyright","label":"Copyright"}]}}